A PHASE II STUDY OF AMRUBICIN AND CARBOPLATIN FOR PREVIOUSLY UNTREATED PATIENTS WITH EXTENSIVE-DISEASE SMALL CELL LUNG CANCER

被引：0
|
作者：
Ikeda, Takaya [1 ]
Taniguchi, Hirokazu [1 ]
Soda, Hiroshi [1 ]
Fukuda, Minoru [2 ]
Kinoshita, Akihito [3 ]
Fukuda, Masaaki [4 ]
Soejima, Yoshifumi [5 ]
Ogawara, Daiki [6 ]
Nakamura, Yoichi [6 ]
Kohno, Shigeru [6 ]
机构：
[1] Sasebo City Gen Hosp, Hirase, Sasebo, Japan
[2] Japanese Red Cross Nagasaki, Isahaya, Nagasaki, Japan
[3] Nagasaki Prefecture Shimabara Hosp, Shimabara, Nagasaki, Japan
[4] Natl Hosp, Org Nagasaki Med Ctr, Omura, Nagasaki, Japan
[5] Ureshino Med Ctr, Ureshina, Japan
[6] Nagasaki Univ Hosp, Dept Internal Med 2, Nagasaki, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
Extensive-Disease Small Cell Lung Cancer; amrubicin; chemotherapy; Carboplatin;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.10-005
引用
收藏
页码：S1157 / S1157
页数：1
相关论文
共 50 条
  • [1] A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer
    Takaya Ikeda
    Minoru Fukuda
    Yoichi Nakamura
    Akitoshi Kinoshita
    Hiroaki Senju
    Hirofumi Nakano
    Takeshi Kitazaki
    Daiki Ogawara
    Hirokazu Taniguchi
    Kohei Motoshima
    Hiroyuki Yamaguchi
    Katsumi Nakatomi
    Midori Shimada
    Seiji Nagashima
    Kazuhiro Tsukamoto
    Shigeru Kohno
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 497 - 502
  • [2] A PHASE II STUDY OF AMRUBICIN AND CARBOPLATIN FOR PREVIOUSLY UNTREATED PATIENTS WITH EXTENSIVE-DISEASE SMALL CELL LUNG CANCER
    Kinoshita, Akitoshi
    Tomonaga, Nanae
    Saijo, Tomoyuki
    Ikeda, Takaya
    Fukuda, Minoru
    Nakamura, Yoichi
    Senju, Hiroaki
    Nakano, Hirofumi
    Kitazaki, Takeshi
    Ogawara, Daiki
    Taniguchi, Hirokazu
    Motoshima, Kohei
    Yamaguchi, Hiroyuki
    Nakatomi, Katsumi
    Shimada, Midori
    Nagashima, Seiji
    Tsukamoto, Kazuhiro
    Kohno, Shigeru
    RESPIROLOGY, 2014, 19 : 155 - 155
  • [3] A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer
    Ikeda, Takaya
    Fukuda, Minoru
    Nakamura, Yoichi
    Kinoshita, Akitoshi
    Senju, Hiroaki
    Nakano, Hirofumi
    Kitazaki, Takeshi
    Ogawara, Daiki
    Taniguchi, Hirokazu
    Motoshima, Kohei
    Yamaguchi, Hiroyuki
    Nakatomi, Katsumi
    Shimada, Midori
    Nagashima, Seiji
    Tsukamoto, Kazuhiro
    Kohno, Shigeru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (03) : 497 - 502
  • [4] Phase ll study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer
    Fukuda, M. I.
    Kitazaki, T.
    Nakamura, Y.
    Kinoshita, A.
    Fukuda, M. A.
    Takatani, H.
    Soda, H.
    Soejima, Y.
    Nagashima, S.
    Kohno, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S832 - S832
  • [5] A Phase I Study of Amrubicin and Carboplatin for Previously Untreated Patients with Extensive-Disease Small Cell Lung Cancer
    Fukuda, Minoru
    Nakamura, Yoichi
    Kasai, Takashi
    Nagashima, Seiji
    Nakatomi, Katsumi
    Doi, Seiji
    Nakano, Hirofumi
    Takatani, Hiroshi
    Fukuda, Masaaki
    Kinoshita, Akitoshi
    Soda, Hiroshi
    Tsukamoto, Kazuhiro
    Oka, Mikio
    Kohno, Shigeru
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (06) : 741 - 745
  • [6] A phase I study of amrubicin and carboplatin for previously untreated patients with extensive-disease small-cell lung cancer
    Kasai, T.
    Fukuda, M.
    Nakamura, Y.
    Nakatomi, K.
    Iida, T.
    Fukuda, M.
    Kinoshita, A.
    Soda, H.
    Oka, M.
    Kohno, S.
    EJC SUPPLEMENTS, 2009, 7 (02): : 539 - 540
  • [7] A phase I study of amrubicin and carboplatin for previously untreated patients with extensive-disease small-cell lung cancer
    Takemoto, Shinnosuke
    Nagashima, Seiji
    Soda, Hiroshi
    Fukuda, Minoru
    Nakamura, Yoichi
    Iida, Tetsuya
    Nakatomi, Katsumi
    Kasai, Takashi
    Takatani, Hiroshi
    Fukuda, Masaaki
    Kinoshita, Akitoshi
    Soejima, Yoshifumi
    Oka, Mikio
    Kohno, Shigeru
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S468 - S469
  • [8] The phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer
    Choi, Hye Jin
    Kim, Joo Hang
    Sohn, Joo Hyuk
    Kim, Se Kyu
    Lee, Chang Geol
    Cho, Jae Yong
    Kim, Yong Tae
    ANNALS OF ONCOLOGY, 2006, 17 : 225 - 225
  • [9] A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer
    Sohn, Joo Hyuk
    Choi, Hye Jin
    Chang, Joon
    Kim, Se Kyu
    Lee, Chang Geal
    Chung, Kyung Young
    Kim, Dae Joon
    Cho, Byoung Chul
    Shin, Sang Joon
    Moon, Yong Wha
    Kim, Joo-Hang
    LUNG CANCER, 2006, 54 (03) : 365 - 370
  • [10] Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study
    Takashi Yana
    Shunichi Negoro
    Minoru Takada
    Soichiro Yokota
    Yoshiki Takada
    Takahiko Sugiura
    Hidehiko Yamamoto
    Toshiyuki Sawa
    Masaaki Kawahara
    Nobuyuki Katakami
    Yutaka Ariyoshi
    Masahiro Fukuoka
    Investigational New Drugs, 2007, 25 : 253 - 258
12345